MX2019013739A - Particulas revestidas y sus usos. - Google Patents

Particulas revestidas y sus usos.

Info

Publication number
MX2019013739A
MX2019013739A MX2019013739A MX2019013739A MX2019013739A MX 2019013739 A MX2019013739 A MX 2019013739A MX 2019013739 A MX2019013739 A MX 2019013739A MX 2019013739 A MX2019013739 A MX 2019013739A MX 2019013739 A MX2019013739 A MX 2019013739A
Authority
MX
Mexico
Prior art keywords
coated particles
particles
coated
associating
binding
Prior art date
Application number
MX2019013739A
Other languages
English (en)
Inventor
Gambogi Robert
Petersen Latrisha
Peterson Sherket
Glowacki Andrew
Patel Meenakshi
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2019013739A publication Critical patent/MX2019013739A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/622—Coated by organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/624—Coated by macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan partículas revestidas y métodos de su uso para proporcionar beneficios para la salud; mas específicamente, la presente invención proporciona partículas revestidas de aminoácidos y/o polímeros, o partículas revestidas de otros materiales 5 para unirse a, o asociarse de cualquier otra manera con, superficies de la cavidad bucal.
MX2019013739A 2017-05-16 2018-05-16 Particulas revestidas y sus usos. MX2019013739A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762506783P 2017-05-16 2017-05-16
PCT/US2018/032928 WO2018213418A1 (en) 2017-05-16 2018-05-16 Coated particles and their uses

Publications (1)

Publication Number Publication Date
MX2019013739A true MX2019013739A (es) 2020-01-20

Family

ID=62567795

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013739A MX2019013739A (es) 2017-05-16 2018-05-16 Particulas revestidas y sus usos.

Country Status (10)

Country Link
US (2) US11291613B2 (es)
EP (1) EP3634372A1 (es)
JP (1) JP7234138B2 (es)
CN (1) CN110650721A (es)
AU (2) AU2018271102A1 (es)
BR (1) BR112019023287B1 (es)
CA (1) CA3060720A1 (es)
MX (1) MX2019013739A (es)
WO (1) WO2018213418A1 (es)
ZA (1) ZA201908358B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102509794B1 (ko) * 2020-01-09 2023-03-14 고려대학교 산학협력단 아미노산 기반의 항균 항생 계면활성 화합물 및 이를 포함하는 코어-쉘 구조의 나노 복합체
KR102304048B1 (ko) * 2021-01-12 2021-09-27 주식회사 엠알이노베이션 천연 식물 추출물을 포함하는 화장품용 plga 나노입자 및 이의 제조방법
CN115068369B (zh) * 2022-07-21 2022-11-15 北京吾星球科技有限公司 一种阳离子基质缓释体系及其制备方法及用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
US10512597B2 (en) * 2007-09-06 2019-12-24 Colgate-Palmolive Company Controlled surface gelling of mucoadhesive polymers on oral mucosa
WO2010001932A1 (ja) * 2008-07-01 2010-01-07 日東電工株式会社 表面被覆微粒子の医薬組成物
EP3936122A1 (en) * 2008-11-24 2022-01-12 Massachusetts Institute Of Technology Methods and compositions for localized agent delivery
JP2010275249A (ja) 2009-05-29 2010-12-09 Hosokawa Micron Corp 化粧料
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
JP4856752B2 (ja) 2009-11-30 2012-01-18 ホソカワミクロン株式会社 薬物含有ナノ粒子の製造方法
WO2012013577A1 (en) * 2010-07-26 2012-02-02 Laboratorios Miret, S.A. Composition for coating medical devices containing lae and a polycationic amphoteric polymer
JP6017905B2 (ja) 2012-09-24 2016-11-02 花王株式会社 口腔用組成物
CN105142620B (zh) 2013-02-25 2018-09-28 罗切斯特大学 用于受控释放抗生物膜剂的纳米颗粒
US9480703B2 (en) * 2013-10-29 2016-11-01 Shaker A. Mousa Method and composition of glycosaminoglycans in sickle cell and vascular disorders
RU2730515C2 (ru) * 2014-11-11 2020-08-24 Джонсон энд Джонсон Консьюмер Инк. Производные аминокислот и их использование
CN106890105B (zh) * 2017-02-24 2019-06-04 四川大学 一种阳离子纳米颗粒及制备方法和应用

Also Published As

Publication number Publication date
CA3060720A1 (en) 2018-11-22
US11291613B2 (en) 2022-04-05
RU2019141071A (ru) 2021-06-16
US20190083367A1 (en) 2019-03-21
RU2019141071A3 (es) 2021-10-04
EP3634372A1 (en) 2020-04-15
BR112019023287B1 (pt) 2023-02-14
ZA201908358B (en) 2021-07-28
JP2020520929A (ja) 2020-07-16
WO2018213418A1 (en) 2018-11-22
JP7234138B2 (ja) 2023-03-07
CN110650721A (zh) 2020-01-03
AU2024203897A1 (en) 2024-06-27
BR112019023287A8 (pt) 2022-08-09
US11648186B2 (en) 2023-05-16
US20220226205A1 (en) 2022-07-21
AU2018271102A1 (en) 2019-10-31
BR112019023287A2 (pt) 2020-06-16

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
PH12019500709A1 (en) Anti-lag-3 antibodies and methods of use thereof
PH12019500540A1 (en) Anti-pd-1 antibodies and their uses
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
PH12016501644A1 (en) Binding proteins and methods of use thereof
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
AU2017240801A8 (en) Chimeric receptors to FLT3 and methods of use thereof
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
MY193723A (en) Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1
MY191581A (en) Anti-pd-1 antibodies
CR20230163A (es) ANTICUERPOS ANTITAU Y MÉTODOS DE USO (Divisional 2019-0271)
WO2018106776A3 (en) Anti-tau antibodies and methods of their use
WO2018081648A8 (en) ANTI-MIC ANTIBODIES AND METHODS OF USE
MX2019005322A (es) Composiciones de recubrimiento y metodos de uso de las mismas.
PH12018550160A1 (en) NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
PH12018502714A1 (en) Nicotine particles and compositions
EP3522882A4 (en) AMINO ACID COMPOSITIONS AND USES THEREOF
MX340555B (es) Anticuerpos contra il-18r1 y usos de los mismos.
TWD165710S (zh) 電連接器
GB2528421A (en) Methods and processes for application of drug delivery polymeric coatings
MX2019002699A (es) Terapia genica para pacientes con anemia de fanconi.
MX2019013739A (es) Particulas revestidas y sus usos.
EP3639845A4 (en) PHARMACEUTICAL COMPOSITION BASED ON A PROTEIN COMPLEX OF IL-15 AND USES THEREOF
WO2016019036A3 (en) Recombinant collagen iv surrogates and uses thereof
EP3522873A4 (en) COMPOSITIONS AND METHODS FOR TREATING XEROSTOMY